Oral doxepin rinse: The analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 465-470

  Epstein, Joel B ^a,d   Epstein, Joshua D ^b   Epstein, Matthew S ^c   Oien, Hal ^d   Truelove, Edmond L ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d University of Washington ^*  (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTINEOPLASTIC AGENT; BENZYDAMINE; DOXEPIN; MORPHINE;

ADULT; AGED; AGEUSIA; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; BURNING SENSATION; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; ERYTHEMA; FATIGUE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISCOMFORT; MOUTH HYGIENE; MOUTH PAIN; MUCOSA INFLAMMATION; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WHOLE BODY RADIATION;

EID: 33746573369     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000223661.60471.78     Document Type: Article

References (27)

1. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:273-6.
2. Epstein JB, Emerton S, Kolbinson D, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999;21:1-11.
3. Epstein JB, Robertson M, Emerton S, et al. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001;23:389-98.
4. Rose-Ped AM, Bellm LA, Epstein JB, et al. Complications of radiation therapy for head and neck cancers: the patient's perspective. Cancer Nursing 2002;25:461-7.
5. Bellm LA, Epstein JB, Rose-Ped A, et al. Patient reports of complications of bone marrow transplantation. Supp Care Cancer 2000;8:33-9.
6. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 2001;27 (Suppl 2):S3-11.
7. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001;19:2201-5.
8. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66:253-62.
9. Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-9.
10. Tollison CD, Kriegel ML. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J. 1988;81:562-4.
11. Hameroff SR, Cork RC, Scherer K, et al. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry 1982;43:22-7.
12. Richeimer SH, Bajwa ZH, Kahraman SS, et al. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin J Pain 1997;13:324-9.
13. Salem RB, Fischer RG, Beghe C. Acute stomatitis associated with doxepin therapy. Drug Intell Clin Pharm 1981;15:992-3.
14. Sudoh Y, Cahoon EE, De Girolami U, Wang GK. Local anesthetic properties of a novel derivative, N-methyl doxepin, versus doxepin and bupivacaine. Anesth Analg 2004;98:672-6.
15. Kiefer G, Fischer W, Teurestein TJ. Effects of amitriptyline, amitriptylinoxide, doxepine and clozapin on N-methyl-D-aspartate-evoked release of [3H]-acetylcholine in rat caudatoputamen. Arzneimittel-Forshung 1999;49 (10):820-3.
16. Sabroe RA, Kennedy CT, Archer CB. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin. Br J Dermatol 1997;137:386-90.
17. Epstein JB, Truelove EL, Oien H, et al. Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol 2001;37:632-7.
18. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999;85 10:2103-13.
19. Allison PG. Survival analysis using SAS: a practical guide. Cary, NC: SAS Institute, 1995.
20. Vickers ER, Marzbani N, Gerzina TM, et al. Pharmacokinetics of EMLA cream 5% application to oral mucosa. Anesth Prog 1997;44:32-7.
21. Epstein JB, Silverman JrS Paggiarino DA, et al. Cl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92:875-85.
22. Epstein JB, Raber-Durlacher JE. Topical agents for the management of oral complications in cancer patients. Business Briefing: U.S. Oncology Review 2004;83-84;999-1004.
23. Elad S, Cohen G, Zylber-Katz E, et al. Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients. J Oral Pathol Med 1999;28:170-2.
24. Epstein JB, Truelove EL, Oien H, et al. Oral topical doxepin rinse: anesthetic effect in normal subjects. Pain Res Manag 2003;8:195-7.
25. Krajnik M, Zylicz Z, Finlay I, et al. Potential uses of topical opioids in palliative care-report of 6 cases. Pain 1999;80:121-5.
26. Cerchietti LC, Navigante AH, Bonomi MR, et al Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002;95:2230-6.
27. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:774-9.